Glossary

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

AABB
AABB Standards
ABO Discrepancy
Acquired B Antigen
Acute Lung Injury
Acute Normovolemic Hemodilution (ANH)
ADAMTS13
Adsorbed Serum/Plasma
Adsorption
Adult T-cell Leukemia/Lymphoma
Agglutination
AHG Crossmatch
AHG Phase
Alexander Wiener
Allele
Alloadsorption
Alloantibody
Allogeneic
Alloimmunization
Antibody Screen
Antithetical
Apheresis
Apheresis Platelets
Apheresis Platelets Leukocyte-Reduced
Autoadsorption
Autoantibody
Autologous

Babesia
Back Type
Blood Assurance Program
Blood Bank
Blood Banking
Blood Group Antigen
Blood Group System
Blood Management
Bombay Phenotype

Daratumumab
DAT
DDAVP
Deconstruction
Deferral
Deglyced
Deglycerolized
Dengue Virus
DHQ
Direct Antiglobulin Test
Direct Exclusion
Directed Donation
Discriminatory NAT
Dolichos biflorus
Donor History Questionnaire
Donor Incentive
Dosage Effect
Double Dose
DTT

EGA
ELISA/EIA
Electronic Crossmatch
Eluate
Elution
Endothelial Cells
Enzyme Immunoassay
Enzymes
Epitope
Extravascular Hemolysis

f Antigen
Factor IX Complex Concentrate
Fresh Frozen Plasma (FFP)
Final Rule
Food and Drug Administration
Forward Grouping
Front Type

G Antigen
Gel Testing
GMP
Graft-vs-Host Disease (GVHD)

H Antigen
H Gene
Haplotype
Hemagglutination
Hematopoietic Progenitor Cell
Hematopoietic Stem Cell
Hematuria
Hemolysis
Hemolytic Uremic Syndrome
HEMPAS
HLA Alloimmunization
Homologous
HPC
HSC
HTLV
HTLV-associated Myelopathy
HUS

IAT
IgG
IgM
Immediate Spin Crossmatch
Immediate Spin Phase
Incubation Period
Indefinite Deferral
Indirect Antiglobulin Test
Indirect Exclusion
Infectious Disease Testing
Injectable Plasma Derivatives
Installation Qualification
Intravascular Hemolysis
Irradiation
ISBT
ISBT 128
Isoantibody
Isohemagglutinin
Isoimmunization

K antigen
Kernicterus
Kleihauer-Betke Test

Label
Least Incompatible
Lectins
Leukocyte Reduction
Liquid Plasma
LISS
Lookback
LRBC

Major Crossmatch
Malaria
Malaria-endemic Area
Malaria-endemic Country
Massive Transfusion
Matuhasi-Ogata Phenomenon
McLeod Phenotype
Minipool
Minor Crossmatch
Multiplex NAT

NAT
Neonatal Alloimmune Thrombocytopenia
Noninjectable Plasma Derivatives
Nucleic Acid Testing

O_h Phenotype
Open System
Operational Qualification

Quad Pack
Quality Assurance
Quality Control
Quality Management
Quarantine

Random Platelets
RBC
Reactive
Recovered Plasma
Red Blood Cells Leukocytes-Reduced
Red Blood Cells Low Volume
Re-entry
Resident
RESt
Reticulocyte Separation
Reverse Grouping
Rh Immune Globulin (RhIg)
ROTEM

Secretor
Serologic Crossmatch
Serum Grouping
Shelf Life
Single Dose
Solid-phase Testing
Source Plasma
Swirling

T Activation
TEG
Teratogen
Thawed Plasma
Thermal Range
Thromboelastography (TEG)
Thrombotic Microangiopathy (TMA)
Thrombotic Thrombocytopenic Purpura (TTP)
Tn Polyagglutination
Transfusion Medicine
Transfusion-related Acute Lung Injury
Traveler
TRICC Study
Tropical Spastic Paraparesis
Tube Testing

UDHQ
Ulex europaeus
ULvWF
Unexpected Antibodies
Universal Donor
Universal Recipient
Urticarial Transfusion Reaction

Validation
Variant CJD
Vasovagal Reaction
Vel System
Viscoelastic Hemostatic Assays (VHAs)
Vitamin-K Dependent Factors
von Willebrand Factor (vWF)

Warm Autoantibodies
WBD Platelets
WBIT
Weak D Phenotype
Whole Blood
Window Period

Xenotransplantation

Zika Virus
ZZAP

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

AABB
AABB Standards
ABO Discrepancy
Acquired B Antigen
Acute Lung Injury
Acute Normovolemic Hemodilution (ANH)
ADAMTS13
Adsorbed Serum/Plasma
Adsorption
Adult T-cell Leukemia/Lymphoma
Agglutination
AHG Crossmatch
AHG Phase
Alexander Wiener
Allele
Alloadsorption
Alloantibody
Allogeneic
Alloimmunization
Antibody Screen
Antithetical
Apheresis
Apheresis Platelets
Apheresis Platelets Leukocyte-Reduced
Autoadsorption
Autoantibody
Autologous

Babesia
Back Type
Blood Assurance Program
Blood Bank
Blood Banking
Blood Group Antigen
Blood Group System
Blood Management
Bombay Phenotype

Daratumumab
DAT
DDAVP
Deconstruction
Deferral
Deglyced
Deglycerolized
Dengue Virus
DHQ
Direct Antiglobulin Test
Direct Exclusion
Directed Donation
Discriminatory NAT
Dolichos biflorus
Donor History Questionnaire
Donor Incentive
Dosage Effect
Double Dose
DTT

EGA
ELISA/EIA
Electronic Crossmatch
Eluate
Elution
Endothelial Cells
Enzyme Immunoassay
Enzymes
Epitope
Extravascular Hemolysis

f Antigen
Factor IX Complex Concentrate
Fresh Frozen Plasma (FFP)
Final Rule
Food and Drug Administration
Forward Grouping
Front Type

G Antigen
Gel Testing
GMP
Graft-vs-Host Disease (GVHD)

H Antigen
H Gene
Haplotype
Hemagglutination
Hematopoietic Progenitor Cell
Hematopoietic Stem Cell
Hematuria
Hemolysis
Hemolytic Uremic Syndrome
HEMPAS
HLA Alloimmunization
Homologous
HPC
HSC
HTLV
HTLV-associated Myelopathy
HUS

IAT
IgG
IgM
Immediate Spin Crossmatch
Immediate Spin Phase
Incubation Period
Indefinite Deferral
Indirect Antiglobulin Test
Indirect Exclusion
Infectious Disease Testing
Injectable Plasma Derivatives
Installation Qualification
Intravascular Hemolysis
Irradiation
ISBT
ISBT 128
Isoantibody
Isohemagglutinin
Isoimmunization

K antigen
Kernicterus
Kleihauer-Betke Test

Label
Least Incompatible
Lectins
Leukocyte Reduction
Liquid Plasma
LISS
Lookback
LRBC

Major Crossmatch
Malaria
Malaria-endemic Area
Malaria-endemic Country
Massive Transfusion
Matuhasi-Ogata Phenomenon
McLeod Phenotype
Minipool
Minor Crossmatch
Multiplex NAT

NAT
Neonatal Alloimmune Thrombocytopenia
Noninjectable Plasma Derivatives
Nucleic Acid Testing

O_h Phenotype
Open System
Operational Qualification

Quad Pack
Quality Assurance
Quality Control
Quality Management
Quarantine

Random Platelets
RBC
Reactive
Recovered Plasma
Red Blood Cells Leukocytes-Reduced
Red Blood Cells Low Volume
Re-entry
Resident
RESt
Reticulocyte Separation
Reverse Grouping
Rh Immune Globulin (RhIg)
ROTEM

Secretor
Serologic Crossmatch
Serum Grouping
Shelf Life
Single Dose
Solid-phase Testing
Source Plasma
Swirling

T Activation
TEG
Teratogen
Thawed Plasma
Thermal Range
Thromboelastography (TEG)
Thrombotic Microangiopathy (TMA)
Thrombotic Thrombocytopenic Purpura (TTP)
Tn Polyagglutination
Transfusion Medicine
Transfusion-related Acute Lung Injury
Traveler
TRICC Study
Tropical Spastic Paraparesis
Tube Testing

UDHQ
Ulex europaeus
ULvWF
Unexpected Antibodies
Universal Donor
Universal Recipient
Urticarial Transfusion Reaction

Validation
Variant CJD
Vasovagal Reaction
Vel System
Viscoelastic Hemostatic Assays (VHAs)
Vitamin-K Dependent Factors
von Willebrand Factor (vWF)

Warm Autoantibodies
WBD Platelets
WBIT
Weak D Phenotype
Whole Blood
Window Period

Xenotransplantation

Zika Virus
ZZAP

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

B

Babesia
Back Type
Blood Assurance Program
Blood Bank
Blood Banking

Blood Group Antigen
Blood Group System
Blood Management
Bombay Phenotype

D

Daratumumab
DAT
DDAVP
Deconstruction
Deferral
Deglyced
Deglycerolized
Dengue Virus
DHQ
Direct Antiglobulin Test

Direct Exclusion
Directed Donation
Discriminatory NAT
Dolichos biflorus
Donor History Questionnaire
Donor Incentive
Dosage Effect
Double Dose
DTT

E

EGA
ELISA/EIA
Electronic Crossmatch
Eluate
Elution

Endothelial Cells
Enzyme Immunoassay
Enzymes
Epitope
Extravascular Hemolysis

F

f Antigen
Factor IX Complex Concentrate
Fresh Frozen Plasma (FFP)
Final Rule

Food and Drug Administration
Forward Grouping
Front Type

G

G Antigen
Gel Testing
GMP
Graft-vs-Host Disease (GVHD)

H

H Antigen
H Gene
Haplotype
Hemagglutination
Hematopoietic Progenitor Cell
Hematopoietic Stem Cell
Hematuria
Hemolysis
Hemolytic Uremic Syndrome

HEMPAS
HLA Alloimmunization
Homologous
HPC
HSC
HTLV
HTLV-associated Myelopathy
HUS

I

IAT
IgG
IgM
Immediate Spin Crossmatch
Immediate Spin Phase
Incubation Period
Indefinite Deferral
Indirect Antiglobulin Test
Indirect Exclusion
Infectious Disease Testing

Injectable Plasma Derivatives
Installation Qualification
Intravascular Hemolysis
Irradiation
ISBT
ISBT 128
Isoantibody
Isohemagglutinin
Isoimmunization

J

K

K antigen
Kernicterus
Kleihauer-Betke Test

L

Label
Least Incompatible
Lectins
Leukocyte Reduction

Liquid Plasma
LISS
Lookback
LRBC

M

Major Crossmatch
Malaria
Malaria-endemic Area
Malaria-endemic Country
Massive Transfusion

Matuhasi-Ogata Phenomenon
McLeod Phenotype
Minipool
Minor Crossmatch
Multiplex NAT

N

NAT
Neonatal Alloimmune Thrombocytopenia
Noninjectable Plasma Derivatives
Nucleic Acid Testing

O

O_h Phenotype
Open System
Operational Qualification

Q

Quad Pack
Quality Assurance
Quality Control

Quality Management
Quarantine

R

Random Platelets
RBC
Reactive
Recovered Plasma
Red Blood Cells Leukocytes-Reduced
Red Blood Cells Low Volume
Re-entry

Resident
RESt
Reticulocyte Separation
Reverse Grouping
Rh Immune Globulin (RhIg)
ROTEM

S

Secretor
Serologic Crossmatch
Serum Grouping
Shelf Life

Single Dose
Solid-phase Testing
Source Plasma
Swirling

T

T Activation
TEG
Teratogen
Thawed Plasma
Thermal Range
Thromboelastography (TEG)
Thrombotic Microangiopathy (TMA)
Thrombotic Thrombocytopenic Purpura (TTP)

Tn Polyagglutination
Transfusion Medicine
Transfusion-related Acute Lung Injury
Traveler
TRICC Study
Tropical Spastic Paraparesis
Tube Testing

U

UDHQ
Ulex europaeus
ULvWF
Unexpected Antibodies

Universal Donor
Universal Recipient
Urticarial Transfusion Reaction

V

Validation
Variant CJD
Vasovagal Reaction
Vel System

Viscoelastic Hemostatic Assays (VHAs)
Vitamin-K Dependent Factors
von Willebrand Factor (vWF)

W

Warm Autoantibodies
WBD Platelets
WBIT

Weak D Phenotype
Whole Blood
Window Period

X

Xenotransplantation

Y

Z

Zika Virus
ZZAP

Pin It on Pinterest